VIENNA, Austria – An agreement between INTERPOL and the United Nations Office on Drugs and Crime (UNODC) will further enhance cooperation between the two organizations in their joint efforts to combat transnational crime and terrorism.
Signed by INTERPOL Secretary General Jürgen Stock and UNODC Executive Director Yury Fedotov the agreement will see the implementation of a Joint Action Plan across six common areas; terrorism, illicit trafficking and organized crime, cybercrime, maritime and border security, forensic and criminal justice capacity, and institutional capacity.
The announcement, made during the Commission on Crime Prevention and Criminal Justice (CCPCJ), will also see the two organizations develop joint initiatives and closer cooperation in the promotion and use of INTERPOL’s policing capabilities alongside UNODC technical assistance initiatives.
“INTERPOL and the UNODC have been working closely together for many years, and this agreement will provide a more strategic, forward-looking orientation for our partnership,” said Secretary General Stock.
“The increasingly complex nature of terrorism and organized crime requires a coherent and effective global response to better protect citizens and infrastructures around the world.
“This agreement will assist in avoiding the risk of overlooking any gaps or overlap in areas covered by our work to better support national crime prevention efforts,” concluded the INTERPOL Chief.
“The need for global partnerships to address shared challenges, from advancing sustainable development to countering the threats posed by transnational organized crime and terrorism, has never been more clear,” said UNODC Executive Director Yury Fedotov.
Recent examples of successful cooperation between INTERPOL and UNODC include the European Union-funded Operation Folosa in September 2015. Targeting drug trafficking from Latin America to Europe via Africa the operation resulted in the seizure of nearly 170 kilogrammes of drugs worth an estimated EUR 10 million, as well as gold coins and stolen credit cards.
In April, on behalf of the UNODC, INTERPOL’s Counterfeit and Security Documents Branch delivered a security document examination workshop in Ghana for the African region to help prevent and combat the smuggling of migrants.
Within the Network of the Law Enforcement Training Institutions (LE TrainNet) initiative, in June 2016 the INTERPOL Global Complex for Innovation in Singapore will host a joint UNODC and INTERPOL meeting to address a range of topics including cybercrime and money laundering.
The agreement between the UNODC and INTERPOL – which will be submitted to the INTERPOL General Assembly in November for approval ̶ will also provide a framework for cooperation in the delivery of the UN’s Sustainable Development Goals, in particular the implementation of Goal 16 and its associated targets of promoting peaceful, fair and inclusive societies.
If proven by law enforcement investigators that illegal drug activities like selling and using indeed happened at the Close Up Forever Summer Concert where five participants died in Pasay City last month, organizers may be held liable for violation of Section 6 of Republic Act 9165 or the Comprehensive Dangerous Drugs Act of 2002 on the maintenance of den, dive or resort. The concert venue may be construed as a den where illegal drug activities take place.
In case where deaths occurred due to drug use, Sec. 6 also provides for a fine ranging from P1-M to P15-M and the death penalty which may be imposed on the maintainer, owner and operator of the activity.
This is what Sec. Felipe L. Rojas, Jr., along with other DDB officials who attended the House probe on the Pasay concert deaths on Monday told the meeting of the joint committees of Dangerous Drugs, Youth and Sports and Metro Manila Development.
DDB Deputy Executive Director for Operations, Asec. Benjamin P. Reyes also presented information on the incident compiled from various reports from the law enforcement.
Policy issues that the DDB will look into were also reported. Some of these are the reclassification of new dangerous drugs, supervision of local government units on events, and liabilities of event organizers and venue owner.
The Dangerous Drugs Board (DDB) is saddened by recent news of lives lost due to alleged drug taking.
As the country’s lead agency on drug prevention and control, the DDB will conscientiously monitor the investigation of this case, make responsible parties answer for any lapses in security and violation of laws, and review existing policies and programs to prevent incidents such as this from happening.
We would also like to remind the public especially the youth to be vigilant and wary especially now that our law enforcement agencies have recorded a rise in the incidence of abuse of new psychoactive substances.
Like what we always say in our campaigns, what these drugs and substances offer is a false panacea. They offer nothing than a false and fleeting high with dangers that can sometimes lead to death.
As we strengthen law enforcement efforts and intelligence operations to arrest drug syndicates and perpetrators, we will also intensify our drug prevention and awareness programs to educate the people on the ill effects of drugs and capacitate and empower them to resist its lures.
To integrate and coordinate efforts of the criminal justice system in the prosecution and criminal investigation of drug-related cases, the Dangerous Drugs Board (DDB) in collaboration with the Philippine Judicial Academy (PhilJa) convened judges, prosecutors and law enforcers from Region IV in a seminar-workshop on RA 9165 or the Comprehensive Dangerous Drugs Act of 2002.
Held on May 17-20 at Taal Vista Hotel, Tagaytay City, the seminar-workshop aimed to update the participants on the list of dangerous drugs and controlled chemicals and to apprise them of RA 9165 provisions and other DDB regulations.
The event likewise served as a forum to identify problems encountered in prosecuting drug-related cases, enhance knowledge on handling drug evidence, and share well-tested trial techniques backed by new procedures and latest jurisprudence.
DDB Chairman Sec. Felipe L. Rojas, Jr., led the opening ceremonies and expressed his joy over the support and participation of the criminal justice pillars.
The seminar, according to Sec. Rojas, shows the intensified effort of the government against illegal drugs. “Our assembly today signifies that we are not letting down on our fight against drugs, nor are we cutting lose our reign on programs that counter this menace,” Sec. Rojas said.
Parole and Probation Officers (PPOs) from NCR, Regions II to V and CAR are now authorized to process petitions for confinement to treatment and rehabilitation centers.
In an orientation seminar conducted by the Dangerous Drugs Board last week, 96 PPOs were enlisted as DDB-authorized representatives who can now facilitate requests or petitions from drug dependents or their families who wish to be admitted to a treatment and rehabilitation facility.
New DDB-authorized representatives are from the National Capital Region (NCR), Regions II, III, IV, V and Cordillera Administrative Region.
This will answer concerns on the absence of legal officers in the regions to help facilitate petition for confinement to treatment and rehabilitation.
The DDB has a standing Memorandum of Agreement (MOA) with the Parole and Probation Administration (PPA) that authorizes PPOs to be designated as DDB representatives to assist patients from different regions in filing court petitions for treatment and rehabilitation.
During the orientation seminar, Usec. Jose Marlowe S. Pedregosa, DDB Executive Director, emphasized the big role of PPOs in helping provide accessible services to the public especially those in the regions.
Selected PPOs who are now DDB-authorized representatives are oriented on their duties and responsibilities in facilitating and processing petitions for confinement, the treatment and rehabilitation process, as well as the aftercare program.
To all concerned clients and stakeholders:
The Legal Division of the Dangerous Drugs Board receives numerous requests for Certificate of No Controlled Chemicals and Certificate of Exemption. In a bid to efficiently process and proficiently evaluate all these requests, we will be implementing a schedule for the submission of applications and walk-in inquiries.
Starting on 20 July 2015 (Monday), submission of applicants and walk-in inquiries shall be accommodated by our personnel from 8:00 AM to 2:00 PM on regular office days. This will allow us to process applications thereafter.
We are hoping for your understanding and cooperation.
Dangerous Drugs Board
To all Physicians, Dentists, Veterinarians, or Practitioners:
The Department of Health-Special Concerns Technical Cluster-Dangerous Drug Abuse Prevention and Treatment Program (SCTC-DDAPTP) announces the availability of Yellow Prescription Pads for sale at selected DOH distribution sites. (Please see complete list under Downloads section in the side bar portion of the DDB website).
FOR: APPLICANTS FOR ISSUANCE OF CERTIFICATE OF NON-CONTROLLED CHEMICALS AND CERTIFICATE OF EXEMPTION
FROM: DDB LEGAL
Effective February 4, 2015 (Wednesday), all applications and attached annexes for certificate of non-controlled chemicals and certificate of exemtion shall submitted in pdf format of said application and attached annexes to be placed in a CD or USB Flash Drive. The requirement aims to improve file management and reduce paper usage in the office.
Applications submitted after the said date without the soft copy requirement shall not be accepted.
Thank you for your cooperation.
Please enclose a SELF - ADDRESSED STAMPED ENVELOPE if you wish to have your certification / exemption mailed to your company through registered mail only. Please ensure that you have placed the proper amount of stamps in a legal - size envelope in order to have the certification / exemption delivered through registerd mail.
TO: ALL PHYSICIANS, DENTISTS, VETERINARIANS AND PHARMACISTS
In the interest of public service, please be informed that due to unavailability of the DOH-Special Prescription Form (Yellow Pad), the use of Ordinary Personalized Prescription Form is HEREBY EXTENDED UNTIL SUCH TIME THE DOH SPECIAL PRESCRIPTION FORMS shall be readily available.
Furthermore, the same shall be in triplicate form, the ordinary copy of which shall be surrendered to the drugstore or pharmacy that dispense the dangerous drugs, the duplicate copy shall remain with the patient or purchaser-representative, and the third copy shall be retained by the prescribing physician.
This advisory shall take effect immediately.
(Sgd) Undersecretary JOSE MARLOWE S. PEDREGOSA
05 April 2013